Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder

NCT04693351 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

589

Enrollment

INDUSTRY

Sponsor class

Conditions

Obsessive-Compulsive Disorder

Interventions

DRUG: Troriluzole
DRUG: Placebo

Sponsor

Biohaven Pharmaceuticals, Inc.